Skip to main content

Advertisement

SpringerLink
Log in

The role of prophylactic antimicrobials during autologous stem cell transplantation: a single-center experience

  • Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

The aim of this study was to investigate the efficacy of antibiotic prophylaxis in patients undergoing autologous stem cell transplantation (ASCT) for multiple myeloma and non-Hodgkin lymphoma. Among 232 ASCT cases performed at the Asan Medical Center, 114 cases underwent treatment with ciprofloxacin, fluconazole, and acyclovir (between January 2001 and August 2005), while 118 cases were performed without antimicrobial prophylaxis (between February 2004 and June 2008). The two-rate χ2 test was applied to accommodate the differences in neutropenia duration. The incidence of febrile episodes was 9.8 cases per 100 person-days in the prophylactic group, while it was 16.2 cases in the no-prophylactic group (p < 0.001). The rate of unexplained fever was 8.0 cases per 100 person-days in the prophylactic group, while it was 13.8 cases in the no-prophylactic group (p < 0.001). The rate of clinically and microbiologically documented infection was 1.7 cases per 100 person-days in the prophylactic group, while it was 2.3 cases in the no-prophylactic group (p = 0.404). There were fewer cases of methicillin-susceptible Staphylococcus aureus infection and a greater number of quinolone-resistant Escherichia coli in the prophylactic group compared with the no-prophylactic group (p = 0.056 and p = 0.040, respectively). The prophylactic antimicrobials reduced the incidence rate of febrile episodes, especially unexplained fever, despite there being no difference in the incidence of documented infection. Resistant microbe infection occurred more frequently in the prophylactic group.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Sepkowitz KA (2002) Antibiotic prophylaxis in patients receiving hematopoietic stem cell transplant. Bone Marrow Transplant 29(5):367–371

    Article  PubMed  CAS  Google Scholar 

  2. Momin F, Chandrasekar PH (1995) Antimicrobial prophylaxis in bone marrow transplantation. Ann Intern Med 123(3):205–215

    PubMed  CAS  Google Scholar 

  3. Sullivan KM, Dykewicz CA, Longworth DL, Boeckh M, Baden LR, Rubin RH, Sepkowitz KA; Centers for Disease Control and Prevention; Infectious Diseases Society of America; American Society for Blood and Marrow Transplantation Practice Guidelines and beyond (2001) Preventing opportunistic infections after hematopoietic stem cell transplantation: the Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and beyond. Hematology 2001(1):392–421

    Article  Google Scholar 

  4. Reuter S, Kern WV, Sigge A, Döhner H, Marre R, Kern P, von Baum H (2005) Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies. Clin Infect Dis 40(8):1087–1093

    Article  PubMed  CAS  Google Scholar 

  5. Gilbert C, Meisenberg B, Vredenburgh J, Ross M, Hussein A, Perfect J, Peters WP (1994) Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support. J Clin Oncol 12(5):1005–1011

    PubMed  CAS  Google Scholar 

  6. Meisenberg B, Gollard R, Brehm T, McMillan R, Miller W (1996) Prophylactic antibiotics eliminate bacteremia and allow safe outpatient management following high-dose chemotherapy and autologous stem cell rescue. Support Care Cancer 4(5):364–369

    Article  PubMed  CAS  Google Scholar 

  7. Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, Feld R, Pizzo PA, Rolston KV, Shenep JL, Young LS (2002) 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34(6):730–751

    Article  PubMed  Google Scholar 

  8. Hughes WT, Armstrong D, Bodey GP, Brown AE, Edwards JE, Feld R, Pizzo P, Rolston KVI, Shenep JL, Young LS (1997) 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America. Clin Infect Dis 25(3):551–573

    Article  PubMed  CAS  Google Scholar 

  9. Bucaneve G, Castagnola E, Viscoli C, Leibovici L, Menichetti F (2007) Quinolone prophylaxis for bacterial infections in afebrile high risk neutropenic patients. Eur J Cancer Suppl 5(2):5–12

    Article  CAS  Google Scholar 

  10. Cullen M, Steven N, Billingham L, Gaunt C, Hastings M, Simmonds P, Stuart N, Rea D, Bower M, Fernando I, Huddart R, Gollins S, Stanley A; Simple Investigation in Neutropenic Individuals of the Frequency of Infection after Chemotherapy +/- Antibiotic in a Number of Tumours (SIGNIFICANT) Trial Group (2005) Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas. N Engl J Med 353(10):988–998

    Article  PubMed  CAS  Google Scholar 

  11. Engels EA, Lau J, Barza M (1998) Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis. J Clin Oncol 16(3):1179–1187

    PubMed  CAS  Google Scholar 

  12. Tunkel AR, Sepkowitz KA (2002) Infections caused by viridans streptococci in patients with neutropenia. Clin Infect Dis 34(11):1524–1529

    Article  PubMed  Google Scholar 

  13. Bucaneve G, Micozzi A, Menichetti F, Martino P, Dionisi MS, Martinelli G, Allione B, D’Antonio D, Buelli M, Nosari AM, Cilloni D, Zuffa E, Cantaffa R, Specchia G, Amadori S, Fabbiano F, Deliliers GL, Lauria F, Foà R, Del Favero A; Gruppo Italiano Malattie Ematologiche dell’Adulto (GIMEMA) Infection Program (2005) Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med 353(10):977–987

    Article  PubMed  CAS  Google Scholar 

  14. Kerr KG, Armitage HT, McWhinney PHM (1999) Activity of quinolones against viridans group streptococci isolated from blood cultures of patients with haematological malignancy. Support Care Cancer 7(1):28–30

    Article  PubMed  CAS  Google Scholar 

  15. Bochud PY, Eggiman P, Calandra T, Van Melle G, Saghafi L, Francioli P (1994) Bacteremia due to viridans Streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors. Clin Infect Dis 18(1):25–31

    Article  PubMed  CAS  Google Scholar 

  16. Bilgrami S, Feingold JM, Dorsky D, Edwards RL, Clive J, Tutschka PJ (1998) Streptococcus viridans bacteremia following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 21(6):591–595

    Article  PubMed  CAS  Google Scholar 

  17. Yeh S-P, Chiu CF, Lo WJ, Lin CL, Hsueh CT, Liao YM, Shen YC (2003) Low infectious morbidity in patients with heavily pretreated hematological malignancies receiving autologous peripheral blood stem cell transplantation without antimicrobial prophylaxis. Ann Hematol 82(1):24–29

    PubMed  Google Scholar 

  18. Eleutherakis-Papaiakovou E, Kostis E, Migkou M, Christoulas D, Terpos E, Gavriatopoulou M, Roussou M, Bournakis E, Kastritis E, Efstathiou E, Dimopoulos MA, Papadimitriou CA (2010) Prophylactic antibiotics for the prevention of neutropenic fever in patients undergoing autologous stem-cell transplantation: results of a single institution, randomized phase 2 trial. Am J Hematol 85(11):863–867

    Article  PubMed  CAS  Google Scholar 

  19. Krüger WH, Hornung RJ, Hertenstein B, Kern WV, Kröger N, Ljungman P, Zander AR; European group for blood and marrow transplantation (2001) Practices of infectious disease prevention and management during hematopoietic stem cell transplantation: a survey from the European group for blood and marrow transplantation. J Hematother Stem Cell Res 10(6):895–903

    Article  PubMed  Google Scholar 

  20. Mossad SB, Longworth DL, Goormastic M, Serkey JM, Keys TF, Bolwell BJ (1996) Early infectious complications in autologous bone marrow transplantation: a review of 219 patients. Bone Marrow Transplant 18(2):265–271

    PubMed  CAS  Google Scholar 

  21. Hartmann O, Le Corroller AG, Blaise D, Michon J, Philip I, Norol F, Janvier M, Pico JL, Baranzelli MC, Rubie H, Coze C, Pinna A, Méresse V, Benhamou E (1997) Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs. A randomized, controlled trial. Ann Intern Med 126(8):600–607

    PubMed  CAS  Google Scholar 

  22. Nosanchuk JD, Sepkowitz KA, Pearse RN, White MH, Nimer SD, Armstrong D (1996) Infectious complications of autologous bone marrow and peripheral stem cell transplantation for refractory leukemia and lymphoma. Bone Marrow Transplant 18(2):355–359

    PubMed  CAS  Google Scholar 

  23. Auner HW, Sill H, Mulabecirovic A, Linkesch W, Krause R (2002) Infectious complications after autologous hematopoietic stem cell transplantation: comparison of patients with acute myeloid leukemia, malignant lymphoma, and multiple myeloma. Ann Hematol 81(7):374–377

    Article  PubMed  CAS  Google Scholar 

  24. Hidalgo M, Hornedo J, Lumbreras C, Trigo JM, Gómez C, Perea S, Ruiz A, Hitt R, Cortés-Funes H (1997) Lack of ability of ciprofloxacin–rifampin prophylaxis to decrease infection-related morbidity in neutropenic patients given cytotoxic therapy and peripheral blood stem cell transplants. Antimicrob Agents Chemother 41(5):1175–1177

    PubMed  CAS  Google Scholar 

  25. Koya R, Andersen J, Fernandez H, Goodman M, Spector N, Smith R, Hanlon J, Cassileth PA (1998) Analysis of the value of empiric vancomycin administration in febrile neutropenia occurring after autologous peripheral blood stem cell transplants. Bone Marrow Transplant 21(9):923–926

    Article  PubMed  CAS  Google Scholar 

  26. Lövenich H, Schütt-Gerowitt H, Keulertz C, Waldschmidt D, Bethe U, Söhngen D, Cornely OA (2005) Failure of anti-infective mouth rinses and concomitant antibiotic prophylaxis to decrease oral mucosal colonization in autologous stem cell transplantation. Bone Marrow Transplant 35(10):997–1001

    Article  PubMed  Google Scholar 

  27. Reich G, Mapara MY, Reichardt P, Dörken B, Maschmeyer G (2001) Infectious complications after high-dose chemotherapy and autologous stem cell transplantation: comparison between patients with lymphoma or multiple myeloma and patients with solid tumors. Bone Marrow Transplant 27(5):525–529

    Article  PubMed  CAS  Google Scholar 

  28. Salazar R, Solá C, Maroto P, Tabernero JM, Brunet J, Verger G, Valentí V, Cancelas JA, Ojeda B, Mendoza L, Rodríguez M, Montesinos J, López-López JJ (1999) Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 23(1):27–33

    Article  PubMed  CAS  Google Scholar 

  29. Sezer O, Eucker J, Bauhuis C, Schweigert M, Lüftner D, Kalus U, Späth-Schwalbe E, Arnold R, Possinger K (2000) Patients with malignant lymphomas experience a higher rate of documented infections than patients with breast cancer after high-dose chemotherapy with autologous peripheral stem cell transplantation. Ann Hematol 79(11):627–630

    Article  PubMed  CAS  Google Scholar 

  30. Solano C, Gutierrez A, Martinez F, Gimeno C, Gómez C, Muñoz I, Faus F, Goterris R, Farga A, Navarro D (2005) Prophylaxis of early bacterial infections after autologous peripheral blood stem cell transplantation (PBSCT): a matched-pair study comparing oral fluoroquinolones and intravenous piperacillin-tazobactam. Bone Marrow Transplant 36(1):59–65

    Article  PubMed  CAS  Google Scholar 

  31. Koo DH, Ko OB, Kim S, Lee DH, Kim SW, Suh C (2006) Prospective randomized comparative observations of infectious complications with or without antimicrobial prophylaxis, during autologous stem cell transplantation. Korean J Hematol 41(4):282–288

    Article  Google Scholar 

  32. Shardell M, Harris AD, El-Kamary SS, Furuno JP, Miller RR, Perencevich EN (2007) Statistical analysis and application of quasi experiments to antimicrobial resistance intervention studies. Clin Infect Dis 45(7):901–907

    Article  PubMed  Google Scholar 

  33. Harris AD, Bradham DD, Baumgarten M, Zuckerman IH, Fink JC, Perencevich EN (2004) The use and interpretation of quasi-experimental studies in infectious diseases. Clin Infect Dis 38(11):1586–1591

    Article  PubMed  Google Scholar 

  34. Fernández-Avilés F, Carreras E, Urbano-Ispizua A, Rovira M, Martínez C, Gaya A, Granell M, Ramiro L, Gallego C, Hernando A, Segura S, García L, González M, Valverde M, Montserrat E (2006) Case–control comparison of at-home to total hospital care for autologous stem-cell transplantation for hematologic malignancies. J Clin Oncol 24(30):4855–4861

    Article  PubMed  Google Scholar 

  35. Herrmann RP, Trent M, Cooney J, Cannell PK (1999) Infections in patients managed at home during autologous stem cell transplantation for lymphoma and multiple myeloma. Bone Marrow Transplant 24(11):1213–1217

    Article  PubMed  CAS  Google Scholar 

  36. Gil L, Styczynski J, Komarnicki M (2007) Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome. Infection 35(6):421–427

    Article  PubMed  CAS  Google Scholar 

  37. National Comprehensive Cancer Network (NCCN) (2009) Prevention and treatment of cancer-related infections: NCCN practice guidelines v.2.2009

  38. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young J-AH, Wingard JR, Infectious Diseases Society of America (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52:e56–e93

    Article  PubMed  Google Scholar 

  39. Craig M, Cumpston AD, Hobbs GR, DeVetten MP, Sarwari AR, Ericson SG (2007) The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit. Bone Marrow Transplant 39(8):477–482

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

There is no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 86 Asanbyeongwon-gil, Songpa-gu, Seoul, 138-736, Korea

    B. S. Sohn, D. H. Yoon, S. Kim, K. Lee, E. H. Kang, J. S. Park, D. H. Lee & C. Suh

  2. Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

    S. H. Kim

  3. Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

    J. Huh

  4. Department of Internal Medicine, College of Medicine, Inje University, Sanggye Paik Hospital, Seoul, Korea

    B. S. Sohn

Authors
  1. B. S. Sohn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. H. Yoon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. H. Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. S. Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. D. H. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. S. H. Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. J. Huh
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. C. Suh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Suh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sohn, B.S., Yoon, D.H., Kim, S. et al. The role of prophylactic antimicrobials during autologous stem cell transplantation: a single-center experience. Eur J Clin Microbiol Infect Dis 31, 1653–1661 (2012). https://doi.org/10.1007/s10096-011-1489-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-011-1489-2

Keywords

Search

Navigation